Pharmaceuticals - Hong Kong

Hong Kong

The Pharmaceuticals market in Hong Kong is anticipated to witness a significant growth in revenue, projected to reach HKD US$1,990.00m by 2024.
Among the various markets, Oncology Drugs is expected to be the largest, with a projected market volume of HKD US$360.30m in the same year.
Furthermore, the market is forecasted to exhibit a steady annual growth rate of 5.33% from 2024 to 2029, resulting in a market volume of HKD US$2,580.00m by 2029.
When compared globally, United States is expected to generate the highest revenue in the Pharmaceuticals market, amounting to US$630.30bn in 2024.
"Pharmaceutical companies in Hong Kong are increasingly focusing on research and development to meet the growing demand for innovative healthcare solutions."

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.

Structure:
The market is subdivided into Oncology Drugs, Anti-Diabetes Drugs, Anti-Rheumatic Drugs, Vaccines, Dermatological Drugs, Antiviral Drugs, Immunosuppressants, Bronchodilator Drugs, Sensory Organ Drugs, Anti-Hypertensive Drugs, Anti-Coagulants, Anti-Fibrinolytic Drugs, Multiple Sclerosis Drugs, Lipid-Lowering Agents and Other Pharmaceuticals. The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs.The Oncology Drugs market covers pharmaceutical products specifically developed for the treatment and management of various cancers. The Anti-Diabetes Drugs market covers medications designed to manage blood glucose levels and improve insulin sensitivity in individuals with diabetes. The market Anti-Rheumatic Drugs includes pharmaceuticals specifically developed to alleviate symptoms, reduce inflammation, and modify the progression of rheumatic diseases. The Dermatological Drugs market covers pharmaceuticals formulated to treat and manage a wide range of skin conditions such as eczema, acne, and rosacea. The Antiviral Drugs market includes medications designed to treat viral infections and reducing the severity and duration of symptoms. The Immunosuppressants market covers pharmaceuticals that suppress the immune system's activity. The Bronchodilator Drugs market covers pharmaceuticals designed to relax and widen the airways in the lungs. The Sensory Organ Drugs market covers pharmaceuticals targeting the treatment of disorders and conditions affecting sensory organs such as the eyes, ears and nose. The Anti-hypertensive Drugs market covers pharmaceuticals designed to lower blood pressure levels. The Anti-Coagulants Drugs market covers pharmaceuticals developed to prevent the formation of blood clots or to dissolve existing clots. The Anti-Fibrinolytics Drugs market covers pharmaceuticals designed to inhibit the breakdown of blood clots. The Multiple Sclerosis Drugs market covers pharmaceuticals aimed at managing and modifying the course of multiple sclerosis. The Lipid-Lowering Agents market covers pharmaceuticals developed to reduce levels of cholesterol and other lipids in the blood. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi.

Market

Region

Region comparison

Currency

Analyst Opinion

The Pharmaceuticals market in Hong Kong has been experiencing steady growth in recent years.

Customer preferences: Hong Kong residents have a strong preference for Western medicine, which has driven the growth of the Pharmaceuticals market. This is due to the perception that Western medicine is more effective and reliable than traditional Chinese medicine. Additionally, an aging population has increased demand for pharmaceutical products, particularly for chronic disease management.

Trends in the market: One trend in the Hong Kong Pharmaceuticals market is an increase in demand for generic drugs. This is due to the government's efforts to reduce healthcare costs and promote the use of affordable drugs. Another trend is the growing popularity of e-commerce platforms for purchasing pharmaceutical products. This is driven by the convenience and accessibility of online shopping, particularly for those who may have difficulty traveling to physical stores.

Local special circumstances: Hong Kong's status as a global financial hub has attracted many multinational pharmaceutical companies to establish a presence in the region. This has led to increased competition and innovation in the market. Additionally, the government has implemented policies to promote the development of the local pharmaceutical industry, particularly in the areas of research and development.

Underlying macroeconomic factors: Hong Kong's strong economic growth and high per capita income have contributed to the growth of the Pharmaceuticals market. Additionally, the government's commitment to healthcare infrastructure and investment in research and development have created a favorable environment for the industry. However, the ongoing political instability and uncertain future relationship with Mainland China may pose challenges for the market in the future.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.